Ken Griffin's position in Novo Nordisk is currently worth $150 Million. That's 0.15% of their equity portfolio (160th largest holding). The first Novo Nordisk trade was made in Q3 2014. Since then Ken Griffin bought shares 57 more times and sold shares on 49 occasions. The investor's estimated purchase price is $234 Million, resulting in a loss of 36%.